Body Mass Index & Joint Replacement
Body mass index (BMI) comes up in almost every conversation about hip and knee replacement — as a risk factor, sometimes as a barrier to referral, and often as a source of frustration for patients who feel judged rather than helped. This article sets out what the evidence actually shows, stage by stage: anaesthesia, recovery, rehabilitation, and the specific issues that differ between hip and knee surgery.
Overview
NICE guidance does not set a fixed BMI limit for referral to hip or knee replacement — clinicians are advised not to restrict access to surgery on the basis of BMI alone. In practice, however, many local NHS areas apply their own commissioning policies, and BMI thresholds of 35 or 40 kg/m² are common, either as a hard cut-off or as a trigger for a supervised weight management pathway before listing. This creates real variation depending on where you live, which is a source of understandable frustration.
The clinical picture is more nuanced than a single number. BMI is a genuine, dose-dependent risk factor — complication rates rise as BMI rises, without a sharp cut-off where risk suddenly appears — but it is one risk factor among several, alongside diabetes control, smoking, cardiovascular fitness and frailty. The purpose of assessing BMI before surgery is not to exclude people; it is to plan the safest possible operation and recovery for that individual, and to give an honest picture of the risks involved.
Anaesthesia
Higher BMI changes anaesthetic planning more than it changes the operation itself. Airway management can be more difficult, drug dosing has to be calculated carefully, and patients with a higher BMI are more likely to have undiagnosed or diagnosed obstructive sleep apnoea, which increases sensitivity to sedatives, opioids and general anaesthetic agents. For these reasons, anaesthetists will often favour regional anaesthesia — a spinal or nerve block — over a general anaesthetic where it is safe and appropriate to do so, since it avoids airway manipulation and reduces the respiratory depressant load in recovery.
This isn’t a fixed rule. The evidence comparing regional and general anaesthesia in this group is genuinely mixed, and modern general anaesthetic techniques have narrowed the gap. What matters in practice is a proper preoperative anaesthetic assessment — including screening for sleep apnoea — so the technique is chosen for the individual, not applied as a blanket policy.
Recovery
The immediate postoperative period carries a higher, dose-dependent complication rate as BMI rises. Compared with patients of a healthy weight, published data show obese patients are roughly 1.7 times more likely to have a complication of some kind, rising to around 2.2 times at a BMI over 35, 3.7 times over 40, and substantially higher again at the extremes of BMI. Wound healing problems, surgical site infection and venous thromboembolism (blood clots) are the complications that occur more frequently, and hospital stays tend to run longer on average.
None of this means complications are inevitable — most patients with a higher BMI recover without incident — but it does mean recovery is actively managed rather than left to chance: closer wound monitoring, appropriate VTE prophylaxis, and earlier involvement of the wider team if anything looks to be going off track.
Rehabilitation
Early mobilisation matters just as much — arguably more — in patients with a higher BMI, both to protect against blood clots and to rebuild function around a joint carrying more load. The evidence suggests that functional recovery at six months tends to lag behind patients of a healthy weight, but that gap generally narrows by around three years, provided rehabilitation continues consistently.
Prehabilitation — optimising fitness and, where appropriate, achieving some weight loss before surgery — is widely recommended, though the trial evidence for structured prehabilitation programmes specifically improving surgical outcomes is still limited and mixed. What is better supported is that preoperative weight loss interventions, where successfully completed, are associated with fewer postoperative complications. The honest position is that losing weight before surgery helps, but an inability to reach a specific target should not, on its own, be treated as a reason to withhold treatment indefinitely.
Hip-Specific Issues
The complication that stands out specifically for total hip replacement is dislocation. Published series show overweight and obese patients carry a meaningfully higher risk of the hip dislocating after surgery — roughly two-and-a-half to four times higher than patients of a healthy weight, depending on the degree of obesity. This relates partly to soft tissue bulk affecting surgical exposure and component positioning, and partly to the mechanical demands placed on the joint afterwards. Surgical approach, implant selection and precise component positioning all become more important considerations as BMI rises, which is one reason higher-BMI hip replacements are often done by surgeons with particular experience in this group.
Knee-Specific Issues
For total knee replacement, the standout risks are wound-related. Superficial infection rates run roughly one-and-a-half to two times higher in obese patients, and deep infection around two-and-a-half times higher, reflecting the combination of soft tissue coverage, local blood supply and the mechanical stress placed on the wound during early rehabilitation. Surgical exposure and accurate alignment can also be technically more demanding when there is more soft tissue to work around, and patellar tracking is watched particularly closely. As with hip surgery, careful technique and close postoperative wound surveillance materially reduce these risks.
The Bottom Line
BMI is a real and quantifiable risk factor in joint replacement, not a myth and not a reason for blanket exclusion. NICE guidance is clear that it should not, by itself, be used to deny access to surgery — but it should absolutely shape how that surgery, anaesthetic and recovery are planned. The honest conversation with your surgical team is not “are you too heavy for this operation,” but “given everything about you, including your BMI, how do we make this operation as safe as possible.”
References
- Sharma A, et al. Access to hip and knee arthroplasty in England: commissioners’ policies for body mass index and smoking status and implications for integrated care systems. Available at: pmc.ncbi.nlm.nih.gov/articles/PMC9875525
- Reassessing BMI-based access to joint replacement surgery. PLOS Medicine. Available at: journals.plos.org/plosmedicine
- Impact of Obesity on Joint Replacement Surgery Outcomes: A Comparative Study. Available at: pmc.ncbi.nlm.nih.gov/articles/PMC11996087
- High body mass index is associated with increased risk of implant dislocation following primary total hip replacement: 2,106 patients followed for up to 8 years. Acta Orthopaedica. Available at: actaorthop.org/actao/article/view/18877
- Challenges and Complications in Treating Total Knee Arthroplasty in Morbidly Obese Patients. Available at: ncbi.nlm.nih.gov/pmc/articles/PMC11472769
- Impact of spinal versus general anaesthesia on perioperative obstructive sleep apnoea severity in patients undergoing hip arthroplasty: a post hoc analysis of two randomised controlled trials. British Journal of Anaesthesia. Available at: bjanaesthesia.org.uk
- Regional or general anesthesia for fast-track hip and knee replacement — what is the evidence? Available at: ncbi.nlm.nih.gov/pmc/articles/PMC4753997
- The effect of body mass index and preoperative weight loss in people with obesity on postoperative outcomes to 6 months following total hip or knee arthroplasty: a retrospective study. Available at: ncbi.nlm.nih.gov/pmc/articles/PMC10544191
- Prehabilitation in Patients at Risk of Poorer Outcomes Following Total Knee Arthroplasty: A Systematic Review. The Journal of Arthroplasty. Available at: arthroplastyjournal.org
- Preoperative weight loss interventions before total hip and knee arthroplasty: a systematic review of randomized controlled trials. Available at: ncbi.nlm.nih.gov/pmc/articles/PMC11100102
